0001493152-23-011040.txt : 20230405 0001493152-23-011040.hdr.sgml : 20230405 20230405162815 ACCESSION NUMBER: 0001493152-23-011040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230404 FILED AS OF DATE: 20230405 DATE AS OF CHANGE: 20230405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chapman Christopher C JR CENTRAL INDEX KEY: 0001340428 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 23802916 MAIL ADDRESS: STREET 1: C/O STAR SCIENTIFIC, INC. STREET 2: 7475 WISCONSIN AVENUE, SUITE 850 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 623 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 855 N. WOLFE STREET STREET 2: SUITE 623 CITY: BALTIMORE STATE: MD ZIP: 21205 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences, Inc. DATE OF NAME CHANGE: 20170413 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 4 1 ownership.xml X0407 4 2023-04-04 0 0001321834 MyMD Pharmaceuticals, Inc. MYMD 0001340428 Chapman Christopher C JR 855 N. WOLFE STREET, SUITE 601 BALTIMORE MD 21205 1 1 0 0 President, Chief Med. Officer 0 Employee Stock Option (Right to Buy) 1.55 2023-04-04 4 A 0 750000 0 A 2028-04-04 Common Stock 750000 750000 D The stock options vest as follows: (i) 250,000 on the date of grant; (ii) 250,000 on the first anniversary of the date of grant; and (iii) 250,000 on the second anniversary of the date of grant, provided that the Reporting Person remains employed by MyMD Pharmaceuticals, Inc. or a subsidiary on the applicable vesting date. _/s/ Chris Chapman 2023-04-05